St. Jude Research
@stjuderesearch.bsky.social
St. Jude Children's Research Hospital: a leader in research and treatment of pediatric cancer and childhood diseases.
The Pediatric Infectious Diseases Fellowship at St. Jude and @uthsc.bsky.social provides access to leading mentors, research opportunities and career development, preparing fellows to advance care of pediatrics infections with enhanced experience in caring for immunocompromised children.
November 14, 2025 at 7:00 PM
The Pediatric Infectious Diseases Fellowship at St. Jude and @uthsc.bsky.social provides access to leading mentors, research opportunities and career development, preparing fellows to advance care of pediatrics infections with enhanced experience in caring for immunocompromised children.
Nineteen St. Jude scientists have been named to the 2025 Highly Cited Researchers list, the most from St. Jude since the list began. This distinction identifies those whose publications rank in the top 1% for citations, indicating broad influence. ow.ly/HKIk50XrffV
November 13, 2025 at 5:15 PM
Nineteen St. Jude scientists have been named to the 2025 Highly Cited Researchers list, the most from St. Jude since the list began. This distinction identifies those whose publications rank in the top 1% for citations, indicating broad influence. ow.ly/HKIk50XrffV
Translational researchers at St. Jude are advancing pediatric cancer care by moving promising compounds from the lab to clinical trials. This process starts with identifying molecular targets for hard-to-treat childhood cancers. ow.ly/AFNa50Xo1Ez
November 7, 2025 at 3:55 PM
Translational researchers at St. Jude are advancing pediatric cancer care by moving promising compounds from the lab to clinical trials. This process starts with identifying molecular targets for hard-to-treat childhood cancers. ow.ly/AFNa50Xo1Ez
The Bringing Chemistry to Medicine symposium at St. Jude Children’s Research Hospital continues its remarkable growth, welcoming more than 1,000 attendees from 44 countries in 2025. Over six years, the symposium has reached over 3,000 participants from 73 countries.
November 4, 2025 at 4:34 PM
The Bringing Chemistry to Medicine symposium at St. Jude Children’s Research Hospital continues its remarkable growth, welcoming more than 1,000 attendees from 44 countries in 2025. Over six years, the symposium has reached over 3,000 participants from 73 countries.
Understanding the foundational factors affecting health—such as genetics and environment—enables more accurate prediction and prevention of disease in children. St. Jude is advancing detection and treatment to improve outcomes and quality of life.
November 3, 2025 at 7:33 PM
Understanding the foundational factors affecting health—such as genetics and environment—enables more accurate prediction and prevention of disease in children. St. Jude is advancing detection and treatment to improve outcomes and quality of life.
The congress reinforced the need for better access to therapies, regardless of geography or resources. By expanding clinical resources and workforce development, St. Jude continues to advance cures and access to resources worldwide.
October 30, 2025 at 10:23 PM
The congress reinforced the need for better access to therapies, regardless of geography or resources. By expanding clinical resources and workforce development, St. Jude continues to advance cures and access to resources worldwide.
Many pediatric neurological diseases are rare and complex, affecting only a small number of children. GEMINI was created at St. Jude to meet this challenge by identifying genetic mutations and developing targeted therapies, advancing from discovery to clinical trial.
October 28, 2025 at 2:20 PM
Many pediatric neurological diseases are rare and complex, affecting only a small number of children. GEMINI was created at St. Jude to meet this challenge by identifying genetic mutations and developing targeted therapies, advancing from discovery to clinical trial.
P. David Rogers, PharmD, PhD, and J. Paul Taylor, MD, PhD, have been elected to the @nam.edu, one of the highest honors in health and medicine. ow.ly/AjRy50Xf9AX
October 20, 2025 at 8:30 PM
P. David Rogers, PharmD, PhD, and J. Paul Taylor, MD, PhD, have been elected to the @nam.edu, one of the highest honors in health and medicine. ow.ly/AjRy50Xf9AX
Andrew Kleist, MD, PhD, has been named a 2025 @statnews.com Wunderkind. The designation recognizes early-career scientists making breakthrough discoveries in health and medicine. ow.ly/JEjJ50XbWhi
October 15, 2025 at 5:05 PM
Andrew Kleist, MD, PhD, has been named a 2025 @statnews.com Wunderkind. The designation recognizes early-career scientists making breakthrough discoveries in health and medicine. ow.ly/JEjJ50XbWhi
“The KIDS25 BioHackathon demonstrates how we’re building the St. Jude data science workforce for the future. These aren’t just 72 hours of coding; they’re an investment in the people who will drive the mission forward for years to come,” said @renato_umeton, VP of Data Science.
October 13, 2025 at 5:03 PM
“The KIDS25 BioHackathon demonstrates how we’re building the St. Jude data science workforce for the future. These aren’t just 72 hours of coding; they’re an investment in the people who will drive the mission forward for years to come,” said @renato_umeton, VP of Data Science.
This year, 160 participants worked on 21 projects as many groups embraced the use of artificial intelligence (AI) to tackle their challenges. The best overall project was awarded to the team who developed a multi-modal agentic AI system for prioritizing the effects of cancer variants.
October 13, 2025 at 5:03 PM
This year, 160 participants worked on 21 projects as many groups embraced the use of artificial intelligence (AI) to tackle their challenges. The best overall project was awarded to the team who developed a multi-modal agentic AI system for prioritizing the effects of cancer variants.
St. Jude recently hosted the KIDS25 BioHackathon, an event connecting students and professionals in bioinformatics, imaging, data science, artificial intelligence and software engineering to develop solutions addressing real-world research challenges.
October 13, 2025 at 5:03 PM
St. Jude recently hosted the KIDS25 BioHackathon, an event connecting students and professionals in bioinformatics, imaging, data science, artificial intelligence and software engineering to develop solutions addressing real-world research challenges.
St. Jude Children’s Research Hospital has been ranked among the top 10
pediatric cancer hospitals by U.S. News & World Report for the 18th year in a row.
Read more: ow.ly/HNLN50X7PsR
pediatric cancer hospitals by U.S. News & World Report for the 18th year in a row.
Read more: ow.ly/HNLN50X7PsR
October 7, 2025 at 2:57 PM
St. Jude Children’s Research Hospital has been ranked among the top 10
pediatric cancer hospitals by U.S. News & World Report for the 18th year in a row.
Read more: ow.ly/HNLN50X7PsR
pediatric cancer hospitals by U.S. News & World Report for the 18th year in a row.
Read more: ow.ly/HNLN50X7PsR
Proud to be ranked No. 2 on the @Forbes list of Best Employers for Healthcare Professionals! At St. Jude, we invest in our team so they can focus on our lifesaving mission.
ow.ly/HPal50X6mBj
ow.ly/HPal50X6mBj
October 3, 2025 at 6:06 PM
Proud to be ranked No. 2 on the @Forbes list of Best Employers for Healthcare Professionals! At St. Jude, we invest in our team so they can focus on our lifesaving mission.
ow.ly/HPal50X6mBj
ow.ly/HPal50X6mBj
St. Jude researchers are advancing science by harnessing light-based technologies to explore the molecular and cellular mechanisms underlying health and disease. ow.ly/3TEI50X4nsQ
October 1, 2025 at 2:05 PM
St. Jude researchers are advancing science by harnessing light-based technologies to explore the molecular and cellular mechanisms underlying health and disease. ow.ly/3TEI50X4nsQ
At #UNGA80, St. Jude & Uzbekistan co-hosted a landmark side event, united by Bente Mikkelsen’s leadership, 8 first ladies, WHO DG @DrTedros & ministers of health worldwide. Together, we’re advancing global health for children facing catastrophic diseases.
September 30, 2025 at 3:15 PM
At #UNGA80, St. Jude & Uzbekistan co-hosted a landmark side event, united by Bente Mikkelsen’s leadership, 8 first ladies, WHO DG @DrTedros & ministers of health worldwide. Together, we’re advancing global health for children facing catastrophic diseases.
A novel radiotracer, [18F]fluoromannitol, is now entering a first-in-human clinical trial at St. Jude. This PET/CT imaging agent could help clinicians distinguish between disease-related inflammation and bacterial infection in patients with sickle cell disease. ow.ly/PV9u50X3PJn
September 29, 2025 at 9:45 PM
A novel radiotracer, [18F]fluoromannitol, is now entering a first-in-human clinical trial at St. Jude. This PET/CT imaging agent could help clinicians distinguish between disease-related inflammation and bacterial infection in patients with sickle cell disease. ow.ly/PV9u50X3PJn
We have received our third consecutive exceptional rating from the National Cancer Institute as a Comprehensive Cancer Center, the highest distinction awarded. St. Jude remains the only center of its kind devoted solely to children.
Learn more: ow.ly/GPA350X3P3X
Learn more: ow.ly/GPA350X3P3X
September 29, 2025 at 5:18 PM
We have received our third consecutive exceptional rating from the National Cancer Institute as a Comprehensive Cancer Center, the highest distinction awarded. St. Jude remains the only center of its kind devoted solely to children.
Learn more: ow.ly/GPA350X3P3X
Learn more: ow.ly/GPA350X3P3X
“Achieving exceptional status for the third consecutive time is a testament to the work of our faculty and staff members, and the impact this Center has on pediatric cancer research and treatment,” said Charles Roberts, MD, PhD.
September 29, 2025 at 5:10 PM
“Achieving exceptional status for the third consecutive time is a testament to the work of our faculty and staff members, and the impact this Center has on pediatric cancer research and treatment,” said Charles Roberts, MD, PhD.
New study reveals pasteurized milk containing H5N1 influenza viral components poses minimal health risks and doesn’t alter influenza immunity. Regularly drinking contaminated pasteurized milk doesn’t increase flu susceptibility in model systems. ow.ly/stPC50X32eB
September 26, 2025 at 6:05 PM
New study reveals pasteurized milk containing H5N1 influenza viral components poses minimal health risks and doesn’t alter influenza immunity. Regularly drinking contaminated pasteurized milk doesn’t increase flu susceptibility in model systems. ow.ly/stPC50X32eB
St. Jude is a proud partner in the National Cancer Institute’s Childhood Cancer Data Initiative (CCDI) Federation API, which recently celebrated its first anniversary. This Childhood Cancer Awareness Month we highlight this important contribution.
September 24, 2025 at 4:15 PM
St. Jude is a proud partner in the National Cancer Institute’s Childhood Cancer Data Initiative (CCDI) Federation API, which recently celebrated its first anniversary. This Childhood Cancer Awareness Month we highlight this important contribution.
Carlos Rodriguez-Galindo, MD, EVP and Director of St. Jude Global, is at the 80th UN General Assembly to help advance sustainable, collaborative solutions for catastrophic childhood diseases. Watch the video for more on why international partnership matters.
September 23, 2025 at 9:11 PM
Carlos Rodriguez-Galindo, MD, EVP and Director of St. Jude Global, is at the 80th UN General Assembly to help advance sustainable, collaborative solutions for catastrophic childhood diseases. Watch the video for more on why international partnership matters.
St. Jude, the government of Uzbekistan, WHO and Zamin Foundation are co-hosting a 90-minute side event at UN Headquarters after UNGA to highlight how leadership, collaboration and innovation are improving health outcomes for children worldwide.
September 17, 2025 at 11:01 PM
St. Jude, the government of Uzbekistan, WHO and Zamin Foundation are co-hosting a 90-minute side event at UN Headquarters after UNGA to highlight how leadership, collaboration and innovation are improving health outcomes for children worldwide.
A new study shows that combining indisulam with anti-GD2 immunotherapy achieves a complete therapeutic response in preclinical neuroblastoma models, regardless of tumor cell state. This could change the outlook for high-risk patients. ow.ly/yR3i50WY7tK
September 17, 2025 at 2:15 PM
A new study shows that combining indisulam with anti-GD2 immunotherapy achieves a complete therapeutic response in preclinical neuroblastoma models, regardless of tumor cell state. This could change the outlook for high-risk patients. ow.ly/yR3i50WY7tK
Committed to building community, Saikat Nandy, PhD, and Gintvile Valinciute, PhD, serve as career development co-vice chairs of the Postdoctoral Leadership Council. They organize events to provide opportunities for networking and learning about potential career paths.
September 15, 2025 at 6:00 PM
Committed to building community, Saikat Nandy, PhD, and Gintvile Valinciute, PhD, serve as career development co-vice chairs of the Postdoctoral Leadership Council. They organize events to provide opportunities for networking and learning about potential career paths.